Zobrazeno 1 - 10
of 949
pro vyhledávání: '"subcutaneous implantable cardioverter/defibrillator"'
Autor:
Reinhard Vonthein, Benito Baldauf, Stefan Borov, Ernest W. Lau, Marzia Giaccardi, Ojan Assadian, Christelle Haddad, Philippe Chévalier, Kerstin Bode, Paul Foley, Honey Thomas, Niall G. Campbell, Stephanie Fichtner, Luca Donazzan, Felix Pescoller, Rainer Oberhollenzer, Roberto Cemin, Hendrik Bonnemeier
Publikováno v:
Journal of Cardiothoracic Surgery, Vol 19, Iss 1, Pp 1-11 (2024)
Abstract Introduction Infection is a significant complication of cardiac implantable electronic device (CIED) therapy. The European TauroPace™ Registry investigates the safety and efficacy of TauroPace™ (TP), an antimicrobial solution containing
Externí odkaz:
https://doaj.org/article/a77f94b7726c4e89a867211b882389c2
Autor:
Shohei Kataoka, Daigo Yagishita, Kyoichiro Yazaki, Masayuki Sakai, Shun Hasegawa, Satoshi Higuchi, Morio Shoda, Junichi Yamaguchi
Publikováno v:
Journal of Arrhythmia, Vol 40, Iss 3, Pp 639-642 (2024)
Externí odkaz:
https://doaj.org/article/ca0aab252112425b87cc2f6122b0ad8f
Autor:
Maurizio Santomauro, Mario Petretta, Carla Riganti, Mario Alberto Santomauro, Mariarosaria De Luca, Andrea Santomauro, Antonio Cittadini
Publikováno v:
Monaldi Archives for Chest Disease (2024)
Subcutaneous implantable cardioverter-defibrillators (S-ICD) are effective in protecting patients against sudden death but expose them to a higher risk of inappropriate shock (IAS). We performed a systematic search of studies published between Janua
Externí odkaz:
https://doaj.org/article/53eb191b72944987853d1351392a6628
Publikováno v:
Indian Pacing and Electrophysiology Journal, Vol 24, Iss 2, Pp 94-104 (2024)
We present the case of a 16-year-old male pediatric patient diagnosed with hypertrophic cardiomyopathy (HCM, identified as having a high risk of sudden cardiac death (SCD), who underwent a successful subcutaneous implantable cardiac defibrillator (S-
Externí odkaz:
https://doaj.org/article/56fc72b7ef21408eaae0fff9174a19cf
Autor:
Chockalingam A. Narayanan, Nadia Bokhari, Ethan J. Rowin, Martin S. Maron, Barry J. Maron, Mark S. Link, Christopher Madias
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 8 (2024)
Externí odkaz:
https://doaj.org/article/1a7410209bc446f6bdd6dd6bbaf84a51
Oversensing caused by trapped air in the header of subcutaneous cardioverter‐defibrillator generator
Publikováno v:
Journal of Arrhythmia, Vol 39, Iss 5, Pp 803-806 (2023)
Externí odkaz:
https://doaj.org/article/edea63ddbfde43bb8ccf9f6b87255ff1
Publikováno v:
Indian Pacing and Electrophysiology Journal, Vol 23, Iss 4, Pp 126-129 (2023)
Implantation of subcutaneous implantable cardioverter-defibrillator in a patient with existing unipolar pacemaker is against manufacturer recommendations. We report the case of a successful subcutaneous implantable cardioverter-defibrillator implanta
Externí odkaz:
https://doaj.org/article/c664ee9cc0a24721a51a8f0eff6c8742
Autor:
Banveet Kaur Khetarpal, Awad Javaid, Justin Z. Lee, Fred Kusumoto, Siva K. Mulpuru, Dan Sorajja, Yong‐Mei Cha, Komandoor Srivathsan
Publikováno v:
Journal of Arrhythmia, Vol 39, Iss 2, Pp 198-206 (2023)
Abstract Background The incidence and impact of noise in a subcutaneous implantable cardioverter defibrillator (S‐ICD) after left ventricular assist device (LVAD) implantation is not well established. Methods We performed a retrospective study of p
Externí odkaz:
https://doaj.org/article/5659e9847d0b424fb4853e52c1a1a531
Publikováno v:
Research in Cardiovascular Medicine, Vol 12, Iss 2, Pp 69-72 (2023)
Despite many well-documented benefits of the transvenous implantable cardioverter-defibrillator in appropriate patients, there is a strong preference today for subcutaneous implantable cardioverter-defibrillator (S-ICD) implantation due to the signif
Externí odkaz:
https://doaj.org/article/02bfca58d77d4888bc95ab3e4582b20c
Autor:
A. V. Vereshchagina, T. M. Uskach, O. V. Sapelnikov, V. A. Amanatova, I. R. Grishin, A. A. Kulikov, V. S. Kostin, R. S. Akchurin
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 18, Iss 4, Pp 427-432 (2022)
Aim. To study the safety and tolerability of the subcutaneous implantable cardioverter defibrillator (S-ICD) after implantation.Material and methods. The results of 33 patients with implanted S-ICD 6 months follow-up. The criteria for inclusion in th
Externí odkaz:
https://doaj.org/article/20f3bc37b37f4819b2dd1876096a6234